Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 4. Subject (61 years/female) with dermal injection of HA-P in right nasolabial fold (NLF) and HA-G in left NLF. Genzyme 6-point grading scale change.

Published byJayson Floyd Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 4. Subject (61 years/female) with dermal injection of HA-P in right nasolabial fold (NLF) and HA-G in left NLF. Genzyme 6-point grading scale change."— Presentation transcript:

1 Fig. 4. Subject (61 years/female) with dermal injection of HA-P in right nasolabial fold (NLF) and HA-G in left NLF. Genzyme 6-point grading scale change from baseline to 24 weeks. Right: HA-P, 3.6 to 2.3; left: HA-G, 3.3 to 0.3. (A) Baseline, (B) 4 weeks, (C) 12 weeks, and (D) 24 weeks after treatment. HA: hyaluronic acid, HA-G, Glytone 3® (Merz Pharmaceuticals GmbH, Frankfurt, Germany); HA-P, Perlane® (Q-Med AB, Uppsala, Sweden). Fig. 4. Subject (61 years/female) with dermal injection of HA-P in right nasolabial fold (NLF) and HA-G in left NLF. Genzyme 6-point grading scale change from baseline to 24 weeks. Right: HA-P, 3.6 to 2.3; left: HA-G, 3.3 to 0.3. (A) Baseline, (B) 4 weeks, (C) 12 weeks, and (D) 24 weeks after treatment. HA: hyaluronic acid, HA-G, Glytone 3® (Merz Pharmaceuticals GmbH, Frankfurt. . . Ann Dermatol Jun;28(3):

Download ppt "Fig. 4. Subject (61 years/female) with dermal injection of HA-P in right nasolabial fold (NLF) and HA-G in left NLF. Genzyme 6-point grading scale change."

Similar presentations

Fig. 4-1, p. 107. Fig. 4-2, p. 109 Fig. 4-3, p. 110.

Fig. 4-1, p Fig. 4-2, p. 109 Fig. 4-3, p. 110.
Gets ready to lead the way with a skin care breakthrough! A Dermatologist- grade hyaluronic acid facial filler - WITHOUT INJECTIONS!

Gets ready to lead the way with a skin care breakthrough! A Dermatologist- grade hyaluronic acid facial filler - WITHOUT INJECTIONS!
CBER Isolagen Therapy (IT) BLA 125348 FDA Clinical Review Agnes Lim, MD Yao-Yao Zhu, MD, PhD DCEPT/OCTGT/CBER, FDA October 9, 2009 Advisory Committee Meeting.

CBER Isolagen Therapy (IT) BLA FDA Clinical Review Agnes Lim, MD Yao-Yao Zhu, MD, PhD DCEPT/OCTGT/CBER, FDA October 9, 2009 Advisory Committee Meeting.
AB 11 22 33 44 55 66 77 88 99 10  20  19  18  17  16  15  14  13  12  11  21  22  23  24  25  26  27  28.

AB 11 22 33 44 55 66 77 88 99 10  20  19  18  17  16  15  14  13  12  11  21  22  23  24  25  26  27  28.
Soft Tissue Fillers. What are Soft Tissue Fillers? injectable substances  Fat  Hyaluronic Acid  Calcium Hydroxylapatite improve the appearance of fine.

Soft Tissue Fillers. What are Soft Tissue Fillers? injectable substances  Fat  Hyaluronic Acid  Calcium Hydroxylapatite improve the appearance of fine.
Fig. 16-CO, p. 449. Fig. 16-1, p. 450 Fig. 16-2, p. 450.

Fig. 16-CO, p Fig. 16-1, p. 450 Fig. 16-2, p. 450.
P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.

P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.
Fig. 11-1, p. 359. p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.

Fig. 11-1, p p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.
Table 6-1, p. 161. Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.

Table 6-1, p Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.
Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
Hyaluronic (HA) Fillers

Hyaluronic (HA) Fillers
School. Answers to School Questions Question 7th grade Brediceanu 7th grade School No 2 5th grade School no 2 How many years of compulsory education do.

School. Answers to School Questions Question 7th grade Brediceanu 7th grade School No 2 5th grade School no 2 How many years of compulsory education do.
Read, Read, Read, Read, Read!! The following presentation is a review over important computer terms. They are important for you to recognize and understand.

Read, Read, Read, Read, Read!! The following presentation is a review over important computer terms. They are important for you to recognize and understand.
Frequency of COP cells in control mice (caALK2) #1#2#3#4Average (%) Baseline (WT) undetectable0.340.17 Baseline (caALK2) 0.25 Day 20.210.200.21 Day 70.920.400.840.520.67.

Frequency of COP cells in control mice (caALK2) #1#2#3#4Average (%) Baseline (WT) undetectable Baseline (caALK2) 0.25 Day Day
Slide 1Fig 28-CO, p.858. Slide 2Fig 28-1, p.859 Slide 3Fig Q28-19, p.884.

Slide 1Fig 28-CO, p.858. Slide 2Fig 28-1, p.859 Slide 3Fig Q28-19, p.884.
WEEK 1 You have 10 seconds to name…

WEEK 1 You have 10 seconds to name…
YOU CAN DISCOVER YOUR HIDDEN BEAUTY

YOU CAN DISCOVER YOUR HIDDEN BEAUTY
Intra-articular Platelet Rich Plasma and Hyaluronic Acid are effective in Knee Osteoarthritis: A Comparative, Randomized Study Dr (Prof) Raju Vaishya MS(Ortho),FRCS,MCh.

Intra-articular Platelet Rich Plasma and Hyaluronic Acid are effective in Knee Osteoarthritis: A Comparative, Randomized Study Dr (Prof) Raju Vaishya MS(Ortho),FRCS,MCh.
Fig. 2. Clinical images of near total improvement cases. (A) No

Fig. 2. Clinical images of near total improvement cases. (A) No
Wrinkle Severity Rating Scale (WSRS) Training Slides

Wrinkle Severity Rating Scale (WSRS) Training Slides

Similar presentations

Ads by Google